ACT for Older Adults Who Hear Voices (HSCED)
Launched by UNIVERSITY OF NOTTINGHAM · May 14, 2024
Trial Information
Current as of February 18, 2025
Completed
Keywords
ClinConnect Summary
Chief Investigator:
Dr Danielle De Boos
Objectives:
To investigate the efficacy of Acceptance and Commitment Therapy for older adults who hear voices in a Hermeneutic Single-Case Efficacy Design series.
Trial Configuration:
Case study series, recruited from multiple centres.
Settings:
Secondary care older adult mental health service and charity-based support groups.
Sample size estimate:
3
Number of participants:
Three participants. If a participant withdraws, a replacement participant will be sought.
Eligibility criteria:
Individuals who are 65+ years of age, experience modera...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Currently experiences HV
- • 65+ years of age
- • Moderate levels of distress. This will be measured using recommended "Moderate" severity level cut-off scores on the Depression, Anxiety and Stress Scales-21 (Lovibond \& Lovibond, 1995) following the completion of Informed Consent Forms.
- • Having capacity to provide informed consent (in accordance with the Mental Capacity Act)
- • Willingness to engage in the intervention
- Exclusion Criteria:
- • Diagnosis of cognitive impairment or dementia (based on self-report), as this indicates a degree of cognitive impairment that would be difficult to accommodate for.
- • Current engagement with another psychological therapy
- • Unable to independently communicate in English without an interpreter (based on researcher's discretion at recruitment).
Trial Officials
Danielle De Boos, DClinPsy
Study Chair
University of Nottingham
About University Of Nottingham
The University of Nottingham is a leading research institution renowned for its commitment to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university harnesses cutting-edge research and expert faculty to address pressing medical challenges. Through its dedicated clinical trials unit, the University of Nottingham conducts rigorous studies aimed at improving patient outcomes and contributing to the global body of medical knowledge. The institution prioritizes ethical practices and participant safety, ensuring that all trials are designed to uphold the highest standards of scientific integrity and regulatory compliance.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Derby, Derbyshire, United Kingdom
Nottingham, Nottinghamshire, United Kingdom
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0